OPTINOSE INC (OPTN)

US68404V1008 - Common Stock

1.09  -0.1 (-8.4%)

After market: 1.1 +0.01 (+0.92%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to OPTN. OPTN was compared to 198 industry peers in the Pharmaceuticals industry. OPTN has a bad profitability rating. Also its financial health evaluation is rather negative. OPTN is valied quite expensively at the moment, while it does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

OPTN had negative earnings in the past year.
OPTN had a negative operating cash flow in the past year.
In the past 5 years OPTN always reported negative net income.
In the past 5 years OPTN always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of OPTN (-32.93%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -32.93%
ROE N/A
ROIC N/A
ROA(3y)-44.79%
ROA(5y)-50.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

OPTN's Gross Margin of 87.84% is amongst the best of the industry. OPTN outperforms 90.82% of its industry peers.
OPTN's Gross Margin has improved in the last couple of years.
OPTN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 87.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.22%
GM growth 5Y2.53%

0

2. Health

2.1 Basic Checks

OPTN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OPTN has been increased compared to 1 year ago.
Compared to 5 years ago, OPTN has more shares outstanding
The debt/assets ratio for OPTN is higher compared to a year ago.

2.2 Solvency

OPTN has an Altman-Z score of -9.78. This is a bad value and indicates that OPTN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of OPTN (-9.78) is worse than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -9.78
ROIC/WACCN/A
WACC9.63%

2.3 Liquidity

A Current Ratio of 0.60 indicates that OPTN may have some problems paying its short term obligations.
OPTN's Current ratio of 0.60 is on the low side compared to the rest of the industry. OPTN is outperformed by 92.86% of its industry peers.
OPTN has a Quick Ratio of 0.60. This is a bad value and indicates that OPTN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.55, OPTN is not doing good in the industry: 92.35% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.55

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 64.04% over the past year.
OPTN shows a decrease in Revenue. In the last year, the revenue decreased by -6.94%.
OPTN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 58.62% yearly.
EPS 1Y (TTM)64.04%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q47.06%
Revenue 1Y (TTM)-6.94%
Revenue growth 3Y13.06%
Revenue growth 5Y58.62%
Revenue growth Q2Q-4.77%

3.2 Future

The Earnings Per Share is expected to grow by 40.66% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 31.82% on average over the next years. This is a very strong growth
EPS Next Y17.13%
EPS Next 2Y30.73%
EPS Next 3Y31.13%
EPS Next 5Y40.66%
Revenue Next Year29.91%
Revenue Next 2Y35.91%
Revenue Next 3Y30.09%
Revenue Next 5Y31.82%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

OPTN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OPTN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as OPTN's earnings are expected to grow with 31.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.73%
EPS Next 3Y31.13%

0

5. Dividend

5.1 Amount

No dividends for OPTN!.
Industry RankSector Rank
Dividend Yield N/A

OPTINOSE INC

NASDAQ:OPTN (4/16/2024, 3:46:51 PM)

After market: 1.1 +0.01 (+0.92%)

1.09

-0.1 (-8.4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap122.79M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -32.93%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 87.84%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.6
Quick Ratio 0.55
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)64.04%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y17.13%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-6.94%
Revenue growth 3Y13.06%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y